Visgo Therapeutics
Burlington, US · Founded 2013 · Delaware corporation
Founders & leadership
JB
Jeanne BertonisExecutive
PH
Pamela HayExecutive
Reported raises · per SEC filings
Form D private placements$725.3K disclosed across 1 round · 2015
▶$725.3KraisedMar 2015 · 7 investors · Other Health CareRule 506(b)
▶$725.3KraisedMar 2015 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeanne BertonisExecutive Officer, Director
- Pamela HayExecutive Officer, Director
- Offering amount
- $1.1M
- Amount sold
- $725.3K
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Visgo Therapeutics raised?
- Visgo Therapeutics has disclosed $725.3K raised across 1 round.
- Where is Visgo Therapeutics headquartered?
- Visgo Therapeutics is headquartered in Burlington, US.